日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results

吉西他滨膀胱灌注系统联合西曲利单抗或单用西曲利单抗作为肌层浸润性膀胱癌新辅助治疗：SunRISe-4 主要分析和生物标志物结果

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-02382
Necchi, Andrea; Guerrero-Ramos, Félix; Crispen, Paul L; Herrera-Imbroda, Bernardo; Garje, Rohan; Szabados, Bernadett; Peyton, Charles C; Pradere, Benjamin; Ku, Ja Hyeon; Shore, Neal; Bögemann, Martin; Preston, Mark A; Xylinas, Evanguelos; Sanchez de Llano, Cristina; Gong, Cinty; Hasan, Mohamad; Urtishak, Karen; Battaglia, Sebastiano; Stitou, Hind; Bhanvadia, Sumeet; Sweiti, Hussein; Psutka, Sarah P
肿瘤
肿瘤免疫
膀胱癌
发表日期：2026
文献求助 收藏

BCG immunotherapy for bladder cancer triggers systemic and local BCG-specific CD4(+) Th1 responses.

膀胱癌的 BCG 免疫疗法可引发全身和局部 BCG 特异性 CD4(+) Th1 反应。

期刊:iScience
影响因子:4.1
doi:10.1016/j.isci.2026.114676
Rollin Paul, Pluskwa Benjamin, Artru Emilie, Le Vaslot Tristan, Kartasheva-Ebertz Daria, Biron Diane, Bossis Margaux, Onodi Fanny, LeMaoult Joel, Rouas-Freiss Nathalie, Chevalier Mathieu F, Lindestam Arlehamn Cecilia S, Sette Alessandro, Masson-Lecomte Alexandra, Desgrandchamps François, Xylinas Evanguelos, Tonnerre Pierre
肿瘤
T细胞
肿瘤免疫
膀胱癌
CD4
免疫/内分泌
发表日期：2026
文献求助 收藏

Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial

Sasanlimab联合BCG治疗既往未接受过BCG治疗的高危非肌层浸润性膀胱癌：一项随机3期CREST试验

期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-03738-z
Shore, Neal D; Powles, Thomas B; Bedke, Jens; Galsky, Matthew D; Palou Redorta, Joan; Ku, Ja Hyeon; Kretkowski, Michal; Xylinas, Evanguelos; Alekseev, Boris; Ye, Dingwei; Guerrero-Ramos, Félix; Briganti, Alberto; Kulkarni, Girish S; Brinkmann, Julia; Calella, Anna-Maria; Cesari, Rossano; Eccleston, Anthony; Michelon, Elisabete; Vermette, Jennifer; Wei, Caimiao; Steinberg, Gary D
肿瘤
肿瘤免疫
REST
CREST
膀胱癌
发表日期：2025
文献求助 收藏

Author Correction: Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial

作者更正：Sasanlimab联合BCG治疗既往未接受过BCG治疗的高危非肌层浸润性膀胱癌：随机3期CREST试验

期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-03894-2
Shore, Neal D; Powles, Thomas B; Bedke, Jens; Galsky, Matthew D; Palou Redorta, Joan; Ku, Ja Hyeon; Kretkowski, Michal; Xylinas, Evanguelos; Alekseev, Boris; Ye, Dingwei; Guerrero-Ramos, Félix; Briganti, Alberto; Kulkarni, Girish S; Brinkmann, Julia; Calella, Anna-Maria; Cesari, Rossano; Eccleston, Anthony; Michelon, Elisabete; Vermette, Jennifer; Wei, Caimiao; Steinberg, Gary D
肿瘤
肿瘤免疫
REST
CREST
膀胱癌
发表日期：2025
文献求助 收藏

TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study

TAR-200 用于卡介苗治疗无效的高危非肌层浸润性膀胱癌：来自 IIb 期 SunRISe-1 研究的结果

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-01651
Daneshmand, Siamak; Van der Heijden, Michiel S; Jacob, Joseph M; Guerrero-Ramos, Felix; Bögemann, Martin; Simone, Giuseppe; Pieczonka, Christopher M; Casco, Nelson Canales; Zainfeld, Daniel; Spiegelhalder, Philipp; Xylinas, Evanguelos; Cahn, David; Lotan, Yair; Murray, Katie S; Kawahara, Takashi; Stromberg, Katharine; Martin, Jason; Shukla, Abhijit; Cutie, Christopher J; Bertzos, Kristi; Hampras, Shalaka; Sweiti, Hussein; Necchi, Andrea
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏

Arterial Embolization versus Robotic Partial Nephrectomy for the Treatment of Renal Angiomyolipomas

动脉栓塞术与机器人辅助部分肾切除术治疗肾血管平滑肌脂肪瘤的比较

期刊:International Braz J Urol
影响因子:4.5
doi:10.1590/S1677-5538.IBJU.2025.0163
Ouzaid, Idir; Gabriel, Pierre-Etienne; Lee, Byron; Delporte, Gauthier; Puech, Philippe; Lemaitre, Laurent; Xylinas, Evanguelos; Villers, Arnauld; Haber, Georges-Pascal
发表日期：2025
文献求助 收藏

Therapeutic Intensification Based on Immune Checkpoint Inhibitors in Non-Muscle Invasive Bladder Cancer: State of the Art and Future Perspectives

基于免疫检查点抑制剂的非肌层浸润性膀胱癌强化治疗：现状与展望

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17213555
Gabriel, Pierre-Etienne; Horowitz, Amir; Guerrero-Ramos, Felix; Soria, Francesco; Moschini, Marco; D'Andrea, David; Pradère, Benjamin; Sfakianos, John P; Xylinas, Evanguelos
Checkpoint
肿瘤
肿瘤免疫
膀胱癌
免疫/内分泌
发表日期：2025
文献求助 收藏

External validation of current quality care metrics after radical nephroureterectomy

根治性肾输尿管切除术后现有质量护理指标的外部验证

期刊:Bju International
影响因子:4.4
doi:10.1111/bju.16741
Duquesne, Igor; Gabriel, Pierre-Etienne; Chakra, Mohamad Abou; Moussa, Mohamad; Mansour, Raymond; Borz, Mihnea Bogdan; Duffaut, Louise; Mesnard, Benoit; Ourfali, Said; Mercier, Jeremy; Peyromaure, Michaël; de la Taille, Alexandre; Rigaud, Jérôme; Ruffion, Alain; Panthier, Frédéric; Xylinas, Evanguelos; Masson-Lecomte, Alexandra; Rouprêt, Morgan; Seisen, Thomas; Roumiguié, Mathieu
发表日期：2025
文献求助 收藏

Perioperative outcomes of multiport or single-port, transperitoneal or retroperitoneal robot assisted radical nephroureterectomy: a narrative review

多孔或单孔、经腹膜或腹膜后机器人辅助根治性肾输尿管切除术的围手术期结果：叙述性综述

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1655703
Gabriel, Pierre-Etienne; Shariat, Shahrokh F; Rouprêt, Morgan; Sfakianos, John P; Xylinas, Evanguelos
发表日期：2025
文献求助 收藏

Association of energy source with outcomes in en bloc TURB: secondary analysis of a randomized trial

能量来源与整体式经尿道膀胱肿瘤切除术（TURB）结果的关联：一项随机试验的二次分析

期刊:World Journal of Urology
影响因子:2.9
doi:10.1007/s00345-025-05565-w
Mancon, Stefano; Soria, Francesco; Hurle, Rodolfo; Enikeev, Dmitry; Xylinas, Evanguelos; Lusuardi, Lukas; Heidenreich, Axel; Gontero, Paolo; Compérat, Eva; Shariat, Shahrokh F; D'Andrea, David
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏